Novartis (NYSE: NVS) reported Q3 EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $12.82 billion versus the consensus estimate of $12.79 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.